Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients

Francesco Sofi, F. Cesari, Y. Tu, G. Pratesi, R. Pulli, C. Pratesi, G. F. Gensini, R. Abbate, G. J. Broze

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Introduction: Protein Z is a vitamin K-dependent protein that serves as a cofactor for the inhibition of activated factor X by the serpin protein Z-dependent protease inhibitor (ZPI). Protein Z plasma levels have been shown to be reduced in patients with peripheral arterial disease (PAD), but ZPI levels have not yet been reported. The aim of this study was to more fully assess the protein Z-ZPI system in individuals with atherosclerosis selected by the presence of symptomatic PAD. Materials and methods: Protein Z and ZPI levels were determined in 95 PAD patients (73 males; 22 females) [median age: 73 years (range, 50-86 years)] and in 190 controls comparable for age and gender. Protein Z was measured using a commercial immunoassay, and ZPI was measured with a homemade immunoassay and a functional assay. Results: Protein Z antigen, ZPI antigen and ZPI function were found to be significantly lower in PAD patients with respect to controls [protein Z, median 72.5% (range: 3.4-123.7%) vs. 90.7% (range: 32.1-203.2%), P < 0.0001; ZPI antigen, 86.1% (range: 25.1-149.5%) vs. 93.2% (range: 48.9-171.3%), P = 0.004; ZPI function, 83.5% (range: 21.1-135.25) vs. 97.2% (range: 50.5-175.5%), P < 0.0001]. The lowest tertiles of protein Z antigen [odds ratio (OR).5.4, 95% confidence interval (CI).2.2-13.5, P < 0.0001] and ZPI function (OR 2.4, 95%.CI 1.1-5.5, P = 0.03) were associated with PAD on multivariate analysis after adjustment for age, gender, and traditional cardiovascular risk factors. A significant inverse relationship was also observed between protein Z and ZPI levels and the number of traditional cardiovascular risk factors and the clinical severity of disease (Fontaine stage). Conclusions: Low levels of protein Z antigen and protein Z activity are significantly associated with the occurrence and severity of atherosclerotic PAD.

Original languageEnglish
Pages (from-to)731-735
Number of pages5
JournalJournal of Thrombosis and Haemostasis
Volume7
Issue number5
DOIs
StatePublished - May 4 2009

Keywords

  • Atherosclerosis
  • Peripheral arterial disease
  • Protein
  • Z
  • ZPI

Fingerprint Dive into the research topics of 'Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients'. Together they form a unique fingerprint.

  • Cite this

    Sofi, F., Cesari, F., Tu, Y., Pratesi, G., Pulli, R., Pratesi, C., Gensini, G. F., Abbate, R., & Broze, G. J. (2009). Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients. Journal of Thrombosis and Haemostasis, 7(5), 731-735. https://doi.org/10.1111/j.1538-7836.2009.03325.x